Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: J Immunol. 2017 Mar 31;198(10):3857–3868. doi: 10.4049/jimmunol.1601851

Figure 9. CD137L blockage delays T1D onset in NOD mice.

Figure 9

Starting at 9 weeks of age, NOD female mice were injected every other week for a total of 5 injections with 250μg of anti-CD137L (TKS-1) each treatment or an isotype control antibody. T1D development was monitored weekly using urine glucose strips with onset defined by two consecutive readings of > 250 mg/dl. *P < 0.05 by Log-rank test.